PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Research and Development Center, GlaxoSmithKline (GSK), Siena, Italy.\', \'College of the Holy Cross, Worcester, MA, USA.\', \'GSK Vaccines Institute for Global Health (GVGH), Siena, Italy.\', \'University of Cambridge, Cambridge, UK.\', \'Coalition for Epidemic Preparedness Innovations (CEPI), Oslo, Norway.\', \'University of Cincinnati Children\'s Hospital, Cincinnati, OH, USA.\', \'Harvard T. H. Chan School of Public Health, Boston, MA, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1126/scitranslmed.abn4342
?:doi
?:hasPublicationType
?:journal
  • Science translational medicine
is ?:pmid of
?:pmid
?:pmid
  • 35353544
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 9.7
?:rankingScore_hIndex
  • 147
?:title
  • The trillion dollar vaccine gap.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/35353544>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/35353544>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all